Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision banner updated from v3.6.2 to v3.6.3, indicating a minor internal update to the study page. It does not modify any study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-03T22:09:32.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.2 on the page, representing a small software revision.
    Difference
    0.1%
    Check dated 2026-06-26T23:53:29.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Enrollment is no longer open to participants, and the page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the page revision to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:40:38.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor backend/template update. No study details, eligibility criteria, or locations were changed.
    Difference
    0.1%
    Check dated 2026-06-05T13:11:16.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor site update.
    Difference
    0.1%
    Check dated 2026-05-15T05:57:32.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s release rather than any study-specific information.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:44.000Z thumbnail image

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.